Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients
Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
To Prevent Chemotherapy Induced Ovarian Failure with the gonadotropin-releasing hormone
Agonist Goserelin in Young female Lymphoma Cancer patients Receiving Chemotherapy